ACMIT GMBH

Their core work

ACMIT is an Austrian applied research center specializing in medical technology, particularly surgical robotics, medical imaging, and medical device testing. Their work spans robotic-assisted surgery systems (ophthalmologic and general surgery), 3D ultrasound diagnostics, and regulatory compliance infrastructure for medical devices under the EU Medical Device Regulation (MDR). Based in Wiener Neustadt and linked to the Institute for Medical Engineering and Science/Technology (ima-mst.at), they bridge the gap between clinical needs and engineering solutions.

What they specialise in

How they've shifted over time

ACMIT's early H2020 work (2015-2017) centered on surgical robotics and medical imaging — building physical systems for ophthalmology and vascular diagnostics. From 2018 onward, their focus shifted toward medical device regulation, blockchain-based safety databases, and MDR compliance infrastructure, reflecting the industry-wide impact of the EU's new Medical Device Regulation. The addition of a pure mathematics project (Dynamics) hints at deepening their computational modeling capabilities alongside the regulatory pivot.

ACMIT is moving from building medical devices toward ensuring medical devices meet EU regulatory requirements — positioning themselves at the intersection of MedTech engineering and MDR compliance.

How they like to work

ACMIT operates exclusively as a project participant, never leading consortia — consistent with a specialized technical contributor that brings deep domain expertise rather than project management capacity. With 59 unique partners across just 5 projects, they work in large, diverse consortia (averaging 12+ partners per project). This broad partner base suggests they are valued as a reliable technical partner and are comfortable integrating into large multinational teams.

Despite only 5 projects, ACMIT has built a remarkably wide network of 59 unique consortium partners spanning 18 countries — indicating they consistently join large, internationally diverse consortia rather than working with a fixed circle of repeat collaborators.

What sets them apart

ACMIT combines hands-on medical robotics engineering with deep knowledge of EU medical device regulation — a rare dual competency. Most MedTech research groups focus on either building devices or navigating compliance; ACMIT does both. For consortium builders, this means a single partner who can contribute to prototype development AND regulatory strategy, reducing coordination overhead in medical device projects.

Highlights from their portfolio

• MDOT
  Their largest project (EUR 863K) tackling EU Medical Device Regulation compliance using blockchain and networked databases — directly addressing a pain point for every MedTech company in Europe.
• SARAS
  Smart autonomous robotic assistant surgeon — represents their most advanced surgical robotics work, moving from teleoperated to autonomous surgical systems.
• EurEyeCase
  Early project applying robotics to ophthalmologic micro-surgery, establishing ACMIT's credentials in precision medical robotics.